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Abstract
Background: Medicinal plants have traditionally been used in many parts of the world as alternative medicine.
Many extracts and essential oils isolated from plants have disclosed biological activity, justifying the investigation
of their potential antimicrobial activity. In this study, the in vitro antifungal activity of six Brazilian Cerrado medicinal
plant species were evaluated against clinically relevant Candida species.
Methods: The crude extract plants were evaluated against American Type Culture Collection (ATCC) standard
strains of Candida spp. using disk diffusion method and determining the minimum inhibitory concentration (MIC).
The chemical study results were confirmed by HPLC method.
Results: All six plant species showed antifungal activity. Among the species studied, Eugenia dysenterica and
Pouteria ramiflora showed significant inhibitory activity against C. tropicalis at lowest MIC value of 125 and
500 μg/disc, respectively. The Eugenia dysenterica also disclosed MIC value of 125 μg/disc against C. famata,
250 μg/disc against C. krusei and 500 μg/disc against C. guilliermondii and C. parapsilosis. Pouteria torta, Bauhinia
rufa, Erythroxylum daphnites and Erythroxylum subrotundum showed activity against the yeast strains with MIC
value of 1000 μg/disc. The chemical study of the most bioactive extracts of Eugenia dysenterica and Pouteria
ramiflora revealed catechin derivatives and flavonoids as main components.
Conclusions: All six evaluated plant species showed good antifungal potential against several Candida strains.
However, E .dysenterica and P. ramiflora showed the higher inhibitory effect against the non-albicans Candida
species. Our results may contribute to the continuing search of new natural occurring products with antifungal
activity.
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Background
The genus Candida, that includes about 200 different
species, is a common commensal microorganism of
the human skin and mucosal surfaces. However, some
Candida species are opportunistic pathogens, capable
of causing superficial or systemic infections, mostly in
humans, mainly when debilitated or immunocom-
promised [1]. The systemic infections due to Candida
species are severe infections that can cause high
morbidity and mortality [2]. The invasive Candida
infection represents the most common infection in
hospitals worldwide and has an attributable mortality
of 35 % to 60 %, causing public health and economic
impact, because of high healthcare cost and prolonged
length of hospitalization [3, 4]. Among the pathogenic
species, Candida albicans is the most common cause of
invasive fungal infections in hospital settings, although a
growing number of new cases from non-Candida albicans
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species have been detected. An even greater disparity
occurred with Candida glabrata, which has been iden-
tified as the second most common cause of invasive fungal
infections in North America and fourth in rank order in
Latin America [5]. Candida tropicalis and Candida para-
psilosis have shown increased prevalence worldwide, as
rarer species such as Candida guilliermondii, Candida
pelliculosa, Candida kefyr, Candida rugosa, and Candida
famata have [6].
The limited number of antifungal agents presently
available for the treatment of fungal infections support
the need for more effective and less toxic treatment
strategies in view of the progressive increase in the
frequency of infections by non-albicans Candida spe-
cies, the elevated resistance to antifungal drugs, and the
relative toxicity of the antifungal drugs currently in use
[7]. Besides, selection pressure due to the continuous
exposure of the infectious agent to azoles seems to be the
main cause behind the development of resistance to
fluconazole that has been considered the drug of choice
against Candida species. In spite of its fungistatic nature
a prolonged use of this drug is not advisable considering
the side effects, hence the increased demand for agents
from natural resources as they could presumably act in a
host friendly manner [8, 9]. Medicinal plants have
traditionally been used in many parts of the world as
alternative treatments to traditional medicine [10]. Many
extracts and essential oils isolated from plants have been
shown to exert biological activity justifying the inves-
tigation of their potential antimicrobial activity [11, 12].
Plants of the Cerrado, a tropical highland savanna cove-
ring almost 800,000 sq mi in the Midwestern region of
Brazil have been broadly used in popular medicine [13].
This region is characterized by an enormous range of
plants that have been the focus of several research reports
[14, 15] including the screening of several extracts and
essential oils with potential anticandidiasis activity [16, 17].
In line with these efforts to increasingly exploit the
therapeutic potential of plants of this extremely biodi-
versity rich region in the present study, we tested the
crude extracts of the following botanical species: Eugenia
dysenterica DC. [Hexachlamys macedoi Legrand),
Pouteria ramiflora (Mart.) Radlk, Pouteria torta (Mart.)
Radlk, Bauhinia rufa (Bong.) Steud, Erythroxylum subro-
tundum A. St.-Hil and Erythroxylum daphnites Mart. for
their antifungal activity against American Type Culture
Collection (ATCC) of Candida species standard strains.
Methods
Plant material
Leaves of Eugenia dysenterica DC. (Hexachlamys macedoi
Legrand), Pouteria ramiflora (Mart.) Radlk, Pouteria torta
(Mart.) Radlk, Bauhinia rufa (Bong.) Steud, Erythroxylum
subrotundum A. St.-Hil and Erythroxylum daphnites
Mart. were collected from the Cerrado biome (the Brazil-
ian savanna) in the city of Brasília (Federal District),
located in the Midwestern region of Brazil, and its
surroundings. Botanical identification was performed by
Professors Suelí Maria Gomes and Christopher William
Fagg. The voucher herbarium specimens were deposited
at the Herbarium of the University of Brasília (UB)
(Table 1). All necessary permits were obtained for the
described field studies.
Extraction procedures
Leaves were dried at room temperature and subsequently
powdered in a knife mill (Marconi Laboratory Equipment,
Piracicaba SP, Brazil). The ethanol and hexane crude
extracts were obtained by the following way: plant mate-
rial (40 g) was macerated at room temperature for seven
days (repeated for three times), first with hexane (2 L),
followed by ethanol (2 L). After filtration, the solvents
were removed under reduced pressure, using rotary evap-
orator Hei-Vap coupled to vacuum pump model D-91126
(Heidolph Instruments GmbH & Co KG, Walpersdorfer,
Schwabach) and refrigerator model MX07R-20-HD2E
(Heidolph Instruments GmbH & Co KG, Walpersdorfer,
Schwabach) to keep the temperatures below 40 °C. The
aqueous crude extract was obtained by infusion, using
400 g of plant material and distilled water (3 L). After
filtration procedure, water was removed by lyophilization
using Advantage Plus XL-70 coupled to vacuum pump
model 2005SD and air compressor model 1NNE5 (SP
Scientific, Warminster, PA, EUA).
Fungal strains
American Type Culture Collection (ATCC) standard
strains of Candida guilliermondii (ATCC 6260), Can-
dida tropicalis (ATCC 28707), Candida parapsilosis
(ATCC 22019), Candida albicans (ATCC 90028), Can-
dida glabrata (ATCC 2001), Candida famata (ATCC
62894), and Candida krusei (ATCC 34135) were used to
perform the antifungal activity. The strains were kindly
provided by the Oswaldo Cruz Foundation (FIOCRUZ)
and stored at −20 °C.
Table 1 List of plant species used in the study






Myrtaceae A 914 (UB)
Pouteria ramiflora (Mart.) Radlk Sapotaceae A, E, H 3671 (UB)
Pouteria torta (Mart.) Radlk Sapotaceae E,H 3674 (UB)
Bauhinia rufa (Bong.) Steud Fabaceae A, E, H 32144 (UB)
Erythroxylum subrotundum A. St.-Hil Erythroxylaceae A, E, H 2194 (UB)
Erythroxylum daphnites Mart Erythroxylaceae A, E, H 2193 (UB)
Crude extracts from Leaves: A aqueous, E ethanolic, H hexanic
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Screening of antifungal effect
For the experiment, 1000 μg of each extract were
dissolved in 1 mL of the respective solvent (hexane,
ethanol and distilled water) yielding final stock solutions
with a concentration of 1000 μgmL−1. Six millimeters fil-
ter paper discs were soaked with 10 μL of each extract
stock solution hexanic, ethanolic and aqueous crude
extracts and dried at room temperature. Agar Sabouraud
24 h cultures (35 ± 2 °C) of Candida species were used
in the preparation of an inoculum diluted in a 0.85 % sa-
line solution, obtaining a fungal suspension equivalent to
a 0.5 standard on the McFarland scale (1 × 106 to 5 × 106
cells per mL). On Petri dishes the fungal inoculum was
spread over the surface of Mueller-Hinton + glucose
(2 %) +methylene blue (0.5 μgmL−1) agar medium in
which discs with the extracts and controls were subse-
quently deposited. The reading of the zone of inhibition
was taken after 24 to 48 h of incubation at 35 ± 2 °C
[18, 19]. Fluconazole (25 μg/disc) was used as positive
reference standard and, as negative control filter paper
discs with ethanol, distilled water and hexane.
Minimal Inhibitory Concentrations (MIC) test
Only extracts that disclosed inhibition zone against
the different Candida species underwent the MIC
evaluation in the disc-diffusion assay, this technique
was adapted by Razmavar et al. [19]. The extract
stock solution was twofold diluted by serial dilutions
resulting in concentrations ranging from 500 to 15.6
μgmL−1. After the serial dilutions, 10 μL of each dilution
was soaked into 6 mm filter paper discs that were sub-
sequently dried at room temperature. The fungal ino-
culum was spread over the surface of Mueller-Hinton +
glucose (2 %) +methylene blue (0.5 μgmL−1) agar and
discs were deposited in the culture medium. The plates
were incubated at 35 ± 2 °C for 24 to 48 h [19]. The MIC
(minimum inhibitory concentration) was defined as the
lowest concentration of the tested extracts that was able
to inhibit any visible microbial growth [20]. Solvent free
extract was used as negative control and Fluconazole
(25 μg/disc) was used as positive reference standard.
Apparatus and chromatographic conditions
The extracts were Analyzed using LaChrom Elite
HPLC system (Hitachi, Japan) liquid chromatograph
equipped with L2130 pump, L2200 auto-sampler; L2300
column oven was in set at 25 °C. The detector, L2455
DAD (Hitachi, Japan) was set at 280 nm. Separation was
performed by Purospher Star reverse phase C18e column
(5 μm, 150 mm× 4.6 mm i.d.) in combination with an
appropriate guard column (4 × 4; 5 μm particle size)
(Merck, Germany). The mobile phase was a linear solvent
gradient system consisting of phosphoric acid (1 %) (A)
and CH3CN (B), at a flow rate of 0.6 mL/min. Data
acquisition was performed using EXChrom Elite software
(version 3.3.2 SP1, Scientific Software. Inc.). The com-
pounds present in the extract were characterized accor-
ding to their UV–vis spectra and identified by their
retention time in comparison with those of commercial
standards (catechin, epicatechin, isoquercitrin myrice-
tin, caffeic acid, chlorogenic acid, ferulic acid, kaem-
pherol, rosmarinic acid, hesperentin, hesperidin, ellagic
acid, gallic acid, hyperoside, quercetin, revesratrol, rutin,
vitexin and isovitexin) [14].
Results and discussions
The antifungal activity of crude extracts of Eugenia
dysenterica, Pouteria ramiflora, Pouteria torta, Bauhinia
rufa, Erythroxylum subrotundum and Erythroxylum
daphnites against ATCC standards strains of Candida
spp. are shown in Table 2. The ethanol extract of
Erythroxylum daphnites and all the hexane extract failed
to show any inhibitory activity. However, all aqueous
extracts and the remaining five ethanol extracts showed a
variable inhibitory activity against one or more species of
Candida.
Among all the extracts that were assessed the aqueous
extract of Eugenia dysenterica was the most effective.
Except for C. albicans and C. glabatra in which no
inhibition could be detected, this extract showed signifi-
cant inhibitory activity against C. parapsilosis, C. guillier-
mondii, C. tropicalis, C. krusei and C. famata, with a
zone of inhibition extending from 12 to 15 mm. The
ethanolic extract Pouteria ramiflora also showed signi-
ficant antifungal potential against C. glabrata, C. tropi-
calis and C. krusei, disclosing a zone of inhibition
varying between 10 to 23 mm. Similarly, the ethanol
extract of Pouteria torta and the aqueous extract of
Erythroxylum subrotundum were effective against three
Candida species and showed comparable antifungal
activity against C. parapsilosis (10 and 11 mm), C. guillier-
mondii (10 mm) and C. glabrata (15 and 30 mm). Two
species, C. tropicalis (12 mm) and C. glabrata (20 mm)
were inhibited by aqueous extract of Pouteria ramiflora
while the ethanolic extract of Erythroxylum subrotundum
and the aqueous extract of Bauhinia rufa, revealed anti-
fungal activity against C. parapsilosis (10 mm) and C.
glabrata (20 to 25 mm). Finally, the aqueous extract of
Erythroxylum daphnites and the ethanolic extract of
Bauhinia rufa showed inhibitory effect only against C.
glabrata (24 and 25 mm). In the present study, C. glabrata
was the most sensitive specie to the inhibitory activity of
the majority of the extracts, whereas C. albicans was the
most resistant since none of the assessed extracts showed
any effect on its growth. The other species of Candida
showed variable degrees of resistance and sensitivity to
different extracts that were tested.
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Table 2 Antifungal activity of ATCC strains exerted by plant crude extracts by the Embedded Disc Assay
Strain ATCC Origin Inhibition Diameter (mm)
Aqueous Extract Ethanolic Extract Hexanic Extract
E. dysenterica P. ramiflora E. subrotundum E. dapnites B. rufa P. ramiflora P. torta E. subrotundum E. dapnites B. rufa P. ramiflora P. torta E. subrotundum E. dapnites B. rufa Fluconazole 25 μg
C. glabrata (2001) Feces - 20 30 24 25 23 15 20 - 25 - - - - - 40
C. parapsilosis (22019) Feces 15 - 11 - 10 - 10 10 - - - - - - - 33
C. guilliermondii (6260) Saliva 12 - 10 - - - 10 - - - - - - - - 50
C. tropicalis (28707) Urine 12 12 - - - 13 - - - - - - - - - 30
C. krusei (34135) Clinical Specimen 13 - - - - 10 - - - - - - - - - 18
C. famata (62894) Catheter tip 12 - - - - - - - - - - - - - - 35
C. albicans (90028) Blood - - - - - - - - - - - - - - - 39



















Table 3 The Minimum Inhibitory Concentration (MIC) of ATCC strains of Candida spp. exerted by plant crude extracts by the Embedded Disc Assay
ATCC Origin CIM (μg/disc) Diameter (mm)
Aqueous Extract Ethanolic Extract Hexanic Extract
E. dysenterica P. ramiflora E. subrotundum E. dapnites B. rufa P. ramiflora P. torta E. subrotundum E. dapnites B. rufa P. ramiflora P. torta E. subrotundum E. dapnites B. rufa Fluconazole 25 μg
C. glabrata (2001) Feces - 1000 1000 1000 1000 1000 1000 1000 - 1000 - - - - - 40
C. parapsilosis
(22019)
Feces 500 - 1000 - 1000 - 1000 1000 - - - - - - - 33
C. guilliermondii
(6260)
Saliva 500 - 1000 - - - 1000 - - - - - - - - 50
C. tropicalis (28707) Urine 125 500 - - - 500 - - - - - - - - - 30
C. krusei (34135) Clinical
Specimen
250 - - - - 1000 - - - - - - - - - 18
C. famata (62894) Catheter tip 125 - - - - - - - - - - - - - - 35
C. albicans (90028) Blood - - - - - - - - - - - - - - - 39



















Scarce previous reports exist on the antifungal activity
of the medicinal plants hereby described. In support of
our results Costa et al. [21] described absence of inhibi-
tory activity of E. dysenterica essential oil against C.
albicans although it showed effectiveness against the
pathogenic yeast Cryptococcus. Boleti et al. [22] reported
the antifungal potential of P. torta extract against
different yeasts and filamentous fungi and considered
that the action of the pouterin, a lectin-like protein
found in its seeds, interacting with cell wall carbo-
hydrates of the fungus, results in an inhibitory effect
on the growth. As far as we know antifungal activity
of P. ramiflora, E. subrotundum, E. daphnites and B.
rufa has not be previously reported, although some
studies have identified the presence of alkaloids and
flavonoids in the genus Erythroxylum [23–25] which
may partly explain its activity against Candida. Anti-
fungal activity has also been reported for some species
Bauhinia [26, 27].
In view of the scarcity of data regarding the anti-
fungal activity against Candida yeasts of the plants
tested in the present study and in order to identify
and confirm the possible medicinal potential of the
extracts that had previously disclosed positive results
in an initial screening, i.e. extracts that had exhibited
an inhibition zone ≥ 10 mm against Candida species,
we proceeded to the determination of their final minimal
inhibitory concentration (MIC).
Fig. 1 Chromatography profiles from aqueous and ethanolic leaf extracts from Pouteria ramiflora. a aqueous leaf extract from Pouteria ramiflora
and b ethanolic leaf extract from Pouteria ramiflora
Table 4 Retention time and maximum absorption of
chromatographic peaks found in P. ramiflora extracts
Aqueous leaf extract from
P. ramiflora
Alcoholic leaf extract from
P. ramiflora
Retention Time Lambda max Retention Time Lambda max
23.84 265, 354 23.84 263, 357
24.35 263, 354 24.36 263, 354
25.65 268, 354 25.66 265, 358
27.13 265, 354 27.14 264, 358
28.23 262, 350 28.16 262, 350
Table 5 Retention time and maximum absorption of
chromatographic peaks found in E. dysenterica extracts
Aqueous leaf extract from E. dysenterica
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The results of MIC values from the diverse plant
extracts tested are shown in Table 3. The results con-
firmed that the aqueous extract of E. dysenterica was the
most effective against the different species of Candida.
This extract exhibited respectively a MIC 125 μg/disc
against C. tropicalis and C. famata, a MIC of 250 μg/
disc against C. krusei and a MIC of 500 μg/disc
against C. parapsilosis and C. guilliermondii. On the
other hand, the aqueous and ethanolic extract of P.
ramiflora showed effectivity against C. tropicalis with a
MIC of 500 μg/disc. A MIC of 1000 μg/disc was found on
testing the remaining extracts.
In a second step, considering that the lower the
MIC of a drug, the greater its effectiveness, the
phytochemical composition of E. dysenterica and P.
ramiflora extracts, that had showed a MIC < 1000 μg/
disc, was determined. The identification of the
individual compounds responsible for the antifungal
activity was performed by HPLC. The profiles of the
aqueous and ethanolic extracts of P. ramiflora dis-
closed a large number of similar compounds with five
main peaks (Fig. 1) [14]. The peaks 1–5 have charac-
teristic UV/Vis spectra of flavonoids, with λmax
between 340 and 370 nm (Table 4). Identification of
the peaks by comparison with commercial standards
was not possible. Nevertheless, our P. ramiflora
HPLC results showed similar UV/Vis peaks character-
istic of the spectra of flavonoids as those found by
Arapitsas [28]. Moreover, the peaks found in both ex-
tracts showed maximum absorption around 265 and
354 nm (Table 4) corroborating with maximum
absorption of isorhamnetin derivatives described by
Parejo et al. [29]. Flavonoids are the most studied
groups of phenolic compounds, comprising molecules
with established antifungal properties [30]. The study
of compounds isolated from Calotropis procera Ait




hibitory effects of these compounds on C. tropicalis more-
over against C. albicans [31].
On the other hand, the aqueous extract of E. dysen-
terica showed three main peaks, which have characte-
ristic UV/Vis of catechin derivatives, with maximum
absorbance near 280 nm and no absorption at 320 or
350 nm (Table 5, Fig. 2) [32]. Alves et al. [33]
previously reported antifungal activity against species
Candida of cathechin derivatives extracted from
flowers of Castanea sativa, Filipendula ulmaria, Rosa
micrantha and Cytius multiflorus, and from fresh leaves
of Cistus ladanifer. The polyphenols (catechins and
theaflavins) present in black tea also showed antifungal
activity against species of Candida [34].
Conclusions
All six evaluated plant species showed good antifungal
potential against several Candida strains. E. dysen-
terica and P. ramiflora showed the higher inhibitory
effect against the non-albicans Candida species. The
chemical analysis of E. dysenterica and P. ramiflora
extracts disclosed presence of polyphenols (flavonoids
and catechins), an important chemical class with
antifungal activity. Considering the increasing number
of infections by non-albicans Candida species and
focusing on their importance for public health, our
results may contribute to the continuing search of new
natural occurring products with antifungal activity.
Fig. 2 Chromatography profiles from aqueous leaf extracts from Eugenia dysenterica
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